Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1AReceptors

Abstract
We report here the first direct functional evidence of an increase in the tonic activation of postsynaptic 5-HT1Areceptors by antidepressant treatments. Because 5-HT1Areceptor activation hyperpolarizes and inhibits CA3pyramidal neurons in the dorsal hippocampus, we determined, usingin vivoextracellular recording, whether the selective 5-HT1Areceptor antagonist WAY 100635 could disinhibit these neurons. Unexpectedly, no disinhibition could be detected in controls. However, after long-term treatment with the tricyclic antidepressant imipramine, the selective 5-HT reuptake inhibitor paroxetine, the reversible monoamine oxidase-A inhibitor befloxatone, the α2-adrenergic antagonist mirtazapine, or the 5-HT1Areceptor agonist gepirone or multiple electroconvulsive shock (ECS) administration, WAY 100635 markedly increased (60–200%) the firing activity of CA3pyramidal neurons. Such a disinhibition was absent in rats treated with the nonantidepressant drug chlorpromazine, in rats receiving only one ECS, or in rats receiving multiple ECSs in combination with an intrahippocampal pertussis toxin treatment to inactivate Gi/o-coupled 5-HT1Areceptors. These data indicate that such antidepressant treatments, acting on entirely different primary targets, might alleviate depression by enhancing the tonic activation of forebrain postsynaptic 5-HT1Areceptors.